# Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol

> **NCT00853632** · NA · COMPLETED · sponsor: **Edwards Lifesciences** · enrollment: 329 (actual)

## Conditions studied

- Coronary Artery Disease
- Mitral Valve Regurgitation
- Mitral Valve Incompetence
- Heart Failure

## Interventions

- **DEVICE:** CEP MAGNA MITRAL PERICARDIAL BIOPROSTHESES

## Key facts

- **NCT ID:** NCT00853632
- **Lead sponsor:** Edwards Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2024-03-06
- **Final completion:** 2024-03-06
- **Target enrollment:** 329 (ACTUAL)
- **Last updated:** 2025-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00853632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00853632, "Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00853632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*